Skip to main content

Carlyle Group Inc.

13F filer · CIK 0001527166
Reported Aug 7, 2026
13F portfolio value$10BU.S. long equity reported on 13F
Positions19Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight99.9%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 7, 202619 positions
MDLNMedline Inc.$7.38B73.78%Not reportedNot reportedQ4 2025
SAROStandardAero, Inc.$2.53B25.30%25.56%Not reportedQ4 2024
PHATPhathom Pharmaceuticals, Inc.$37.9M0.38%4.37%Not reportedQ1 2023
INVHInvitation Homes Inc.$20M0.20%0.11%-0.2%Q1 2023
PONYPony AI Inc.$16.4M0.16%0.54%Not reportedQ4 2024
GETYGetty Images Holdings, Inc.$5.36M0.05%1.48%Not reportedQ4 2022
SPRBSpruce Biosciences, Inc.$2.09M0.02%1.40%Not reportedQ1 2023
SPWRSunPower Inc.$1.61M0.02%1.55%+441.1%Q3 2023
ACETAdicet Bio, Inc.$1.59M0.02%1.97%Not reportedQ1 2023
FWRDForward Air Corp$1.45M0.01%0.32%Not reportedQ3 2024
OKUROnKure Therapeutics, Inc.$1.23M0.01%0.67%Not reportedQ4 2024
DNUTKrispy Kreme, Inc.$1.2M0.01%0.20%Not reportedQ1 2024
QTTBQ32 Bio Inc.$769K0.01%0.25%-94.5%Q1 2024
REPXRiley Exploration Permian, Inc.$530K0.01%0.07%Not reportedQ4 2024
NBISNebius Group N.V.$510K0.01%0.00%NewQ2 2026
HOODRobinhood Markets, Inc.$475K0.00%0.00%+40.2%Q4 2024
JSPRJasper Therapeutics, Inc.$449K0.00%3.80%Not reportedQ1 2023
NABLN-able, Inc.$344K0.00%0.05%Not reportedQ1 2024
METCRamaco Resources, Inc.$288K0.00%0.05%Not reportedQ4 2024
Q1 2026Reported May 8, 202620 positions
MDLNMedline Inc.$8.33B78.40%Not reported-13.1%Q4 2025
SAROStandardAero, Inc.$2.18B20.58%25.46%-44.6%Q4 2024
PHATPhathom Pharmaceuticals, Inc.$38.8M0.37%4.40%Not reportedQ1 2023
PONYPony AI Inc.$22.3M0.21%0.54%Not reportedQ4 2024
INVHInvitation Homes Inc.$16.5M0.16%0.11%Not reportedQ1 2023
CUBECubeSmart$8.08M0.08%0.10%Not reportedQ3 2022
QTTBQ32 Bio Inc.$7.08M0.07%7.54%Not reportedQ1 2024
GETYGetty Images Holdings, Inc.$4.95M0.05%1.49%Not reportedQ4 2022
SPRBSpruce Biosciences, Inc.$2.52M0.02%2.81%Not reportedQ1 2023
FWRDForward Air Corp$1.79M0.02%0.34%Not reportedQ3 2024
ACETAdicet Bio, Inc.$1.26M0.01%1.92%Not reportedQ1 2023
DNUTKrispy Kreme, Inc.$1.16M0.01%0.20%Not reportedQ1 2024
OKUROnKure Therapeutics, Inc.$1.12M0.01%1.97%Not reportedQ4 2024
JSPRJasper Therapeutics, Inc.$934K0.01%3.81%Not reportedQ1 2023
SPWRSunPower Inc.$550K0.01%0.36%Not reportedQ3 2023
HTFLHeartflow, Inc.$497K0.00%0.02%NewQ1 2026
SYRESpyre Therapeutics, Inc.$485K0.00%0.01%Not reportedQ4 2023
NABLN-able, Inc.$438K0.00%0.05%Not reportedQ1 2024
XCURExicure, Inc.$240K0.00%0.88%Not reportedQ1 2023
HOODRobinhood Markets, Inc.$234K0.00%0.00%Not reportedQ4 2024
Q4 2025Reported Feb 13, 202620 positions
MDLNMedline Inc.$9.04B66.65%Not reportedNewQ4 2025
SAROStandardAero, Inc.$4.38B32.27%45.67%Not reportedQ4 2024
PHATPhathom Pharmaceuticals, Inc.$58M0.43%4.90%Not reportedQ1 2023
PONYPony AI Inc.$34.3M0.25%0.54%Not reportedQ4 2024
INVHInvitation Homes Inc.$18.5M0.14%0.11%+39.1%Q1 2023
GETYGetty Images Holdings, Inc.$8.35M0.06%1.49%Not reportedQ4 2022
CUBECubeSmart$7.95M0.06%0.10%Not reportedQ3 2022
QTTBQ32 Bio Inc.$3.62M0.03%8.58%Not reportedQ1 2024
SPRBSpruce Biosciences, Inc.$3.3M0.02%2.81%-98.7%Q1 2023
FWRDForward Air Corp$3.09M0.02%0.34%Not reportedQ3 2024
JSPRJasper Therapeutics, Inc.$1.94M0.01%3.81%Not reportedQ1 2023
ACETAdicet Bio, Inc.$1.54M0.01%1.92%0.0%Q1 2023
DNUTKrispy Kreme, Inc.$1.37M0.01%0.20%Not reportedQ1 2024
OKUROnKure Therapeutics, Inc.$772K0.01%80.72%Not reportedQ4 2024
NABLN-able, Inc.$701K0.01%0.05%Not reportedQ1 2024
SPWRSunPower Inc.$680K0.01%0.39%-65.6%Q3 2023
NCNANuCana plc$480K0.00%0.00%Not reportedQ1 2023
HOODRobinhood Markets, Inc.$382K0.00%0.00%Not reportedQ4 2024
SYRESpyre Therapeutics, Inc.$315K0.00%0.01%Not reportedQ4 2023
XCURExicure, Inc.$305K0.00%0.88%-80.0%Q1 2023
Q3 2025Reported Nov 7, 202517 positions
SAROStandardAero, Inc.$4.17B96.05%45.65%Not reportedQ4 2024
PONYPony AI Inc.$53.1M1.22%0.67%Not reportedQ4 2024
PHATPhathom Pharmaceuticals, Inc.$41.1M0.95%4.92%Not reportedQ1 2023
SPRBSpruce Biosciences, Inc.$24.8M0.57%514.03%Not reportedQ1 2023
INVHInvitation Homes Inc.$14M0.32%0.08%Not reportedQ1 2023
GETYGetty Images Holdings, Inc.$12.3M0.28%1.50%Not reportedQ4 2022
CUBECubeSmart$8.97M0.21%0.10%Not reportedQ3 2022
FWRDForward Air Corp$3.14M0.07%0.34%Not reportedQ3 2024
JSPRJasper Therapeutics, Inc.$2.53M0.06%3.81%Not reportedQ1 2023
ACETAdicet Bio, Inc.$2.39M0.06%3.54%Not reportedQ1 2023
SPWRSunPower Inc.$2.22M0.05%1.42%-20.7%Q3 2023
QTTBQ32 Bio Inc.$2.13M0.05%8.96%Not reportedQ1 2024
DNUTKrispy Kreme, Inc.$1.32M0.03%0.20%Not reportedQ1 2024
XCURExicure, Inc.$1.13M0.03%4.42%Not reportedQ1 2023
OKUROnKure Therapeutics, Inc.$742K0.02%80.72%Not reportedQ4 2024
NABLN-able, Inc.$731K0.02%0.05%Not reportedQ1 2024
NCNANuCana plc$619K0.01%18.77%+19900.0%Q1 2023
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.